3
2
1

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

2025/08/15

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

2025/07/03

On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.

Significant Achievements: Successfully Cultivated Human Heart in Pigs, Bringing New Hope for Organ Transplantation

2025/06/19

Recently, the world's top - tier academic journal Nature featured a major research achievement by Chinese scientists on its front - page headlines. For the first time, a heart containing human cells was cultivated in a pig embryo, and this heart could beat autonomously and survived for 21 days. This groundbreaking progress offers a brand - new solution to the global shortage of organ transplants and marks a new stage in the development of xenogeneic organ cultivation technology.

Bountiful Harvest: A Review of Life Extension Plan Scientific Achievements

2025/02/07

With the rapid development of science and technology, humanity's exploration of life has never ceased. During the 2023-2024 period, we witnessed a series of exciting scientific achievements. These not only made significant progress in fields such as anti-aging, gene editing, organ regeneration, and immunotherapy but also pointed the way for future medical research.

2025-11-21

Chinese Team Pioneers "Nano-Armored" CAR-T Cell Therapy, Bringing Hope for Cure to Malignant Mesothelioma

Industry experts believe that this study marks a critical breakthrough for China in the field of tumor immunotherapy. It provides important insights for CAR-T therapy to tackle other solid tumors, such as lung and liver cancer, and will elevate China's level of tumor immunotherapy to new heights.

2025-11-17

"Speaking Through Thoughts" Becomes Reality! China Achieves Real-Time Decoding of Chinese Brain-Computer Interfaces

A groundbreaking research study recently published in the prestigious international academic journal Science Advances reveals a remarkable achievement: a collaborative research team comprising over ten institutions, including Huashan Hospital affiliated with Fudan University, the Shanghai Institute of Microsystem and Information Technology, and ShanghaiTech University, has successfully realized high-precision real-time decoding of a brain-computer interface (BCI) for all Chinese syllables. This research not only brings hope for rehabilitation to individuals with aphasia but also signifies a leap in humanity's ability to interpret linguistic thoughts in the brain, turning "speaking through thoughts" from science fiction into reality.

2025-11-17

Gene Editing Ushers in a Revolution of "Large-Scale Rearrangement"! Bridge Recombinase: The "Magic Pen" Rewriting the Code of Life

With the continuous optimization of bridge recombinase technology, humanity may be just one precise "gene rearrangement" away from conquering many currently incurable diseases.

2025-11-07

Major Breakthrough: Human Kidney Organoids Successfully Transplanted into Pig Kidney, Paving New Path for Regenerative Medicine

On October 21, 2025, researchers from the Catalan Institute of Bioengineering in Spain published a research paper in Nature Biomedical Engineering, announcing a critical advancement in the clinical application of organoid technology, marking a significant milestone for regenerative medicine and personalized healthcare.

2025-11-07

A "Heart" Is Hard to Come By: Experts Call for Accelerating the Establishment of Medium- and Long-Distance Organ Transport Platforms

"If we can achieve a safe preservation time of 8 hours, heart transplantation could be more widely performed in China, allowing surgeons to prepare for surgeries more thoroughly," Sun Wenyu said.

2025-10-14

Neuralink's New Breakthrough: ALS Patient Achieves Autonomous Robotic Arm Control via Brain-Computer Interface

From controlling computers to operating robotic arms, Neuralink is expanding the application of brain-computer interfaces from the digital realm to the physical world. For patients with limited mobility—such as those with ALS or paralysis—this technology not only offers the possibility of "moving again" but also carries the hope of restoring dignity in life. As clinical trials progress, brain-computer interfaces may drive more profound transformations in neurorehabilitation.

2025-09-26

New Research Solves the Problem of Red Blood Cell Cryopreservation, Providing Key Technical Support for Building a Long - Term Blood Bank

This research provides an efficient and safe solution for red blood cell cryopreservation. It also offers important references for the development of preservation technologies for other types of cells such as stem cells and immune cells. It is expected to promote the upgrading of the global blood resource reserve system and provide key technical support for responding to public health emergencies and clinical emergency blood use needs.

2025-09-26

Patient Survives 8 Months after Gene - Edited Pig Kidney Transplant: A Milestone in Xenotransplantation

Recently, Nature News reported a bombshell in the global medical community. Tim Andrews, a 67 - year - old American, has survived eight months after a gene - edited pig kidney transplant. This is not only the longest - lasting case of a pig organ in a living human but also a milestone in xenotransplantation, offering new hope for the global organ shortage.

2025-09-19

Zhejiang University's Run Run Shaw Hospital Develops "Bone Glue", Revolutionizing Orthopedic Treatment

This innovation represents a major breakthrough in China's minimally invasive fracture treatment and brings new hope to global orthopedics.

2025-09-19

"The 'Nobel Prize Indicator': The Lasker Awards Announced - Basic Medicine, Clinical, and Special Achievement Awards Go to Different Recipients

From decoding the cell's "transport code" to developing therapies for genetic diseases, from basic breakthroughs to laying the foundation for disciplines, the 2025 Lasker Award recipients are lighting up the future of medicine with their innovations. As the jury said, "Their work is not only a victory for science but also a milestone in humanity's fight against diseases and exploration of the essence of life."

< 1234...12 >